Fortimel Compact Protein

Frailty & DRM Oncology

Product description

Fortimel Compact Protein is a food for special medical purposes for the dietary management of disease related malnutrition.

For use under medical supervision only, Fortimel Compact Protein is a high protein, high energy medical nutrition supplement. It contains all essential minerals, vitamins and trace elements, providing 18 g of protein and 306 kcal in 125 ml.

Available in the following flavours: Neutral, Banana, Berries, Mocha, Peach, Mango, Strawberry, Vanilla, Cool red fruits and Hot tropical ginger. The flavours Neutral, Cool red fruits and Hot tropical ginger were co-built with cancer patients experiencing taste alteration.

Product information

Ingredients

Water, cow’s milk proteins, maltodextrin, sugar, vegetable oils (rapeseed oil, sunflower oil), magnesium hydrogen phosphate, emulsifier (soy lecithin), flavouring, choline chloride, sodium L-ascorbate, potassium citrate, di potassium hydrogen phosphate, ferrous lactate, DL-α-tocopheryl acetate, colouring (curcumin), retinyl acetate, copper gluconate, zinc sulphate, manganese sulphate, calcium D-pantothenate, sodium selenite, D-biotin, chromium chloride, cholecalciferol, thiamin hydrochloride, pteroylmonoglutamic acid, pyridoxine hydrochloride, nicotinamide, potassium iodide, riboflavin, sodium molybdate, sodium fluoride, cyanocobalamin, phytomenadione

Allergy advice: for allergens see ingredients in bold.

Nutritional Values

Average contents	per 100 ml
Energy:	1010kJ/240kcal
Fat:	9.4g (35 En%)
saturates	0.9g
Carbohydrate:	24.4g (41 En%)
- Sugars	13.3g
- Lactose	0.3g
Fibre:	0g (0 En%)
Protein:	14.4g (24 En%)
Salt:	0.10g
Vitamins:
Vit A	260μg
Vit D	2.1μg
Vit E	3.7mg (α-TE/ET)
Vit K	16μg
Thiamin	0.45mg
Riboflavin	0.50mg
Niacin	0.59mg (3.6mg NE/EN)
Pantothenic acid	1.6mg
Vit. B6	0.53mg
Folic acid	80μg
Vit. B 12	1.1μg
Biotin	12μg
Vit. C	30mg
Minerals and trace elements:
Na	40mg (1.7 mmol)
K	105mg (2.7 mmol)
Cl	60mg (1.7 mmol)
Ca	350mg (8.7 mmol)
P	300mg (9.7 mmol)
PO4	914mg (8.7 mmol)
Mg	55mg (9.7 mmol)
Fe	2.1mg (9.7 mmol)
Zn	2.4mg (2.3 mmol)
Cu	0.35mg
Mn	0.63mg
F	0.19mg
Mo	20μg
Se	14μg
Cr	13μg
l	46μg
Others:
Choline	110mg
Osmolarity	570mOsmol/l

How does Fortimel Compact Protein address taste changes?

Fortimel Compact Protein includes a sensational range of five tailor-made flavors designed to support cancer patients struggling with sensory alterations.

View product

View infographic

Protein is an important nutrient at every stage of the cancer journey

Protein is an important nutrient at every stage of the cancer journey. In patients with cancer, the need for protein is higher than for healthy adults, and cancer patients often fail to consume sufficient protein^2-4. Low protein intake can lead to low muscle mass, fatigue and even poorer survival in patients with cancer^5-8. Therefore, ensuring sufficient protein with high protein oral nutritional supplements can improve clinical outcomes^9-13.

View infographic

Taste can change outcomes shouldn’t

Up to 70% of cancer patients experience taste and smell alterations¹⁴. Sensory changes in cancer contribute to weight loss and malnutrition, increasing the risk of poor clinical outcomes^15-22. Sensory-adapted oral nutritional supplements, such as the Fortimel Compact Protein Sensational flavor range, have been designed and validated with cancer patients experiencing taste and smell alterations.

Nutricia location globe secondary teaser new

Product availability

For information about product availability in your country, click on the button below to be taken to a local website.

Overview country websites

Oncology

The prevalence of malnutrition in cancer patients ranges from 30-80% [1]. The right medical nutritional support helps patients before, during and after treatment.

Back to Oncology

References

Ryan et al. Proc Nutr Soc. 2016;75(2):199-211.
Prado et al. Canadian journal of dietetic practice and research 2012; 73(4):e298-303
McCurdy et al. Nutrients 2019; 11(11)
Stobaus et al. Nutr Cancer 2015; 67(5):818-24
Tobberup et al. Clin Nutr ESPEN 2019; 34:94-100
Capitao et al. Support care cancer 2022; 30(4):3007-3015
Regueme et al. Support Care Cancer 2021; 29(2):687-696
Hasegawa et al. Clin Nutr 2021; 40(7):4792-4798
Kabata et al. Supportive Care in Cancer 2014; 23, 365-370
Cereda et al. Radiother Oncol 2018; 126(1):81-88
Grupinska et al. Nutrients 2021; 13, 3549
Meng et al. Clin Nutr 2021; 40(1):40-46
Manasek et al. Kin Onkol 2016; 29(5):351-357
Spotten et al. Ann Oncol 2017; 28:969-84
Ryan et al. Nutrition 2019; 67-68:110539
Pressoir et al. Br J Cancer 2010; 102 (6), 966-71
Drareni et al. Semin Oncol 2019; 46:160-72
Brisbois et al. J Pain Symptom Manage 2011; 41:673-83
Boltong et al. Support Care Cancer 2012; 20:2765-74
Belqaid et al. Acta Oncol 2014; 53:1405-12
Prado et al. Canadian journal of dietetic practice and research 2012; 73(4):e298-303
McCurdy et al. Nutrients 2019; 11(11)